First read for a new ticker takes about 20–30 seconds while we build the analysis from the latest fundamentals, estimates, and intelligence. It's saved after this, so future visits are instant.
★ Analysts see FY2027 revenue reaching $507.0B — +6.1% growth in a single year.
What Moves the Stock
1Global bicycle sell-through rates at major retailers (REI, Decathlon, specialty bike shops) - inventory destocking has suppressed orders since mid-2022
2OEM production schedules from Trek, Specialized, Giant - typically visible 6-9 months forward through component orders
3Mix shift toward electronic groupsets (Di2, EP8 e-bike motors) which carry 40-50% higher ASPs than mechanical equivalents
4Yen exchange rate fluctuations - approximately 60% of production costs are yen-denominated while 70% of sales are in USD/EUR
5Chinese bicycle market recovery - historically 15-20% of revenue, collapsed during COVID lockdowns
6Bicycle Components (~80% of revenue): derailleurs, brakes, wheels, pedals sold to OEMs (Trek, Specialized, Giant) and aftermarket
7Fishing Equipment (~20% of revenue): reels, rods, lures primarily in Japanese and North American markets
8Other (~1%): rowing equipment and industrial cold forging operations
value - Stock trades at 3.1x sales and 1.7x book despite market leadership and net cash balance, reflecting deep cyclical trough.
Rising interest rates negatively impact Shimano through two channels: (1) reduced consumer financing availability for premium bicycles…
Watch on earnings: US bicycle unit sales (NBDA data) and average selling prices - leading indicator for component demand, European e-bike penetration rates (currently 50% of market, target 65% by 2027), Shimano's order backlog duration disclosed in quarterly results - normalized is 8-12 weeks, peaked at 52+ weeks in 2021.
One Sentence Summary:
Shimano: the story is balanced — global bicycle sell-through rates at major retailers (rei, decathlon, specialty bike shops) - inventory destocking has suppressed orders.
Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.